What is DoseMe?
DoseMe operates within the healthcare technology sector, focusing on the development of sophisticated clinical software solutions. Its core mission is to enable precision dosing of medications across various healthcare environments. The company's flagship platform, DoseMeRx, leverages advanced pharmacokinetic and pharmacodynamic modeling, combined with patient-specific clinical data, to assist clinicians in determining optimal drug dosages. This approach aims to enhance medication safety, improve treatment efficacy, and support evidence-based medical decision-making in hospitals and pharmacies, moving beyond traditional, population-based dosing strategies.
How much funding has DoseMe raised?
DoseMe has raised a total of $3.1M across 2 funding rounds:
Angel/Seed
$500K
Series A
$2.6M
Angel/Seed (2014): $500K, investors not publicly disclosed
Series A (2016): $2.6M, investors not publicly disclosed
What's next for DoseMe?
With the recent major strategic investment and substantial enterprise-level funding, DoseMe is poised for accelerated expansion and further development of its innovative precision dosing technology. The company's focus on integrating advanced modeling with real-time patient data positions it as a key player in the digital health revolution. Future endeavors will likely involve scaling its platform, enhancing its analytical capabilities, and forging deeper partnerships within the healthcare ecosystem to broaden the adoption of model-informed precision dosing, ultimately aiming to set new standards in patient care and medication management.
See full DoseMe company page
